Clinical Trial Update: The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating empagliflozin for renal outcomes in survivors of severe acute kidney injury. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Chulalongkorn University | Conditions: Empagliflozin in Post AKI Stage 2-3 | Phase 1 | Status: ACTIVE_NOT_RECRUITING